NEW YORK (GenomeWeb News) – AB Sciex and Indigo BioSystems today announced an agreement to market mass spectrometry solutions.
The solutions streamline data acquisition and automate data review and are expected to accelerate the use of mass spec technologies by simplifying the workflows. The partnership is also expected to ensure better results in clinical research, forensic toxicology, and pre-clinical and clinical trials of new drugs, AB Sciex and Indigo said.
The terms of the deal call for AB Sciex, a Danaher company, to combine its mass specs with Indigo's software called Ascent to simplify mass spec use for those more accustomed to using easy-to-use lab analyzers.
Financial terms were not disclosed.
"By embedding the knowledge of assay experts into the analysis software, we provide the foundation for smarter research laboratories," Indigo CEO Raul Zavaleta said in a statement.